Pricing
  1. US-listed companies
  2. FILANA THERAPEUTICS, INC.
  3. Financials
  4. Common stock and paid-in capital

FILANA THERAPEUTICS, INC.【FLNA】

Market cap
$106.76M
P/E ratio
SummaryFinancials
Period EndCommon stock and paid-in capital (Million USD)YoY (%)
Dec 31, 2024551+6.29%
Dec 31, 2023518+1.40%
Dec 31, 2022511+10.81%
Dec 31, 2021461+72.66%
Dec 31, 2020267+40.08%
Dec 31, 2019191+3.87%
Dec 31, 2018184+9.87%
Dec 31, 2017167+1.81%
Dec 31, 2016164+2.57%
Dec 31, 2015160+2.21%
Dec 31, 2014157+2.72%
Dec 31, 2013152+2.44%
Dec 31, 2012149-15.69%
Dec 31, 2011176

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)